Barellini Leonardo, Marcasciano Marco, Lo Torto Federico, Fausto Alfonso, Ribuffo Diego, Casella Donato
Unità di Oncologia Chirurgica Ricostruttiva della Mammella, "Spedali Riuniti" di Livorno, Breast Unit Integrata di Livorno, Livorno, Italia.
Unità di Oncologia Chirurgica Ricostruttiva della Mammella, "Spedali Riuniti" di Livorno, Breast Unit Integrata di Livorno, Livorno, Italia; Department of Surgery "P. Valdoni," Unit of Plastic and Reconstructive Surgery, "Sapienza" University of Rome, Rome, Italy.
Clin Breast Cancer. 2020 Jun;20(3):e290-e294. doi: 10.1016/j.clbc.2019.10.004. Epub 2019 Dec 6.
The main goal of oncoplastic breast-conserving surgery (OBCS) is to obtain tumor-free resection margins after cancer excision with satisfactory cosmetic results. Positive tumor margins are associated with high rates of tumor recurrence requiring reoperation. The aim of this prospective clinical trial was to demonstrate the reliability of intraoperative ultrasound (IOUS) to obtain tumor-free resection margins in OBCS.
Between December 2016 and March 2018, data from 130 patients with by T1-2 breast cancer, either invasive or in situ, who underwent OBCS were prospectively collected. The oncoplastic surgeon performed IOUS in the operating theater to localize the lesion and mark its skin projection. Then specimens were examined to assess the presence of the lesion and margin adequacy. Definitive histologic reports were reviewed, with a focus on margin status.
All patients experienced oncoplastic approaches, and lesions were always found on the specimen at the histologic report. In 126 cases (97%), margins were considered adequate. In 17 cases (13%), IOUS showed positive margins, and resection was contextually enlarged. In 12 of these (9%), the pathologic report confirmed the need for enlarged resection. This study shows that IOUS-guided surgery can obtain a high percentage of tumor-free resection margins in OBCS without scheduling conflicts between radiology, nuclear, and surgery departments. Full cooperation between radiologists and oncoplastic surgeons is required to achieve high-standard oncologic and reconstructive outcomes.
IOUS represent an additional tool for the breast surgeon to improve margin-free management of neoplastic lesions, preventing reoperations in patients undergoing oncoplastic surgery.
肿瘤整形保乳手术(OBCS)的主要目标是在切除癌症后获得无肿瘤切缘,同时取得满意的美容效果。阳性肿瘤切缘与高复发率相关,常需再次手术。本前瞻性临床试验的目的是证明术中超声(IOUS)在OBCS中获得无肿瘤切缘的可靠性。
2016年12月至2018年3月,前瞻性收集了130例T1-2期浸润性或原位乳腺癌患者接受OBCS的数据。肿瘤整形外科医生在手术室进行IOUS以定位病变并标记其皮肤投影。然后检查标本以评估病变的存在及切缘是否足够。回顾最终的组织学报告,重点关注切缘状态。
所有患者均采用肿瘤整形方法,组织学报告显示标本上均发现病变。126例(97%)切缘被认为足够。17例(13%)IOUS显示切缘阳性,同时扩大了切除范围。其中12例(9%)病理报告证实需要扩大切除。本研究表明,IOUS引导的手术在OBCS中可获得高比例的无肿瘤切缘,且无需放射科、核医学科和外科之间安排冲突的时间。放射科医生和肿瘤整形外科医生之间需要充分合作以实现高标准的肿瘤学和重建效果。
IOUS是乳腺外科医生改善肿瘤病变无切缘管理的额外工具,可防止接受肿瘤整形手术的患者再次手术。